EyePoint Pharmaceuticals
EYPT
#6801
Rank
A$0.77 B
Marketcap
$11.36
Share price
-0.28%
Change (1 day)
-65.79%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Cash on Hand

Cash on Hand as of September 2024 : A$0.40 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has A$0.40 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

EyePoint Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.48 B128.74%
2022-12-31A$0.21 B-27.2%
2021-12-31A$0.29 B399.64%
2020-12-31A$58.4 M84.08%
2019-12-31A$31.72 M
2018-06-30A$52.37 M138.22%
2017-06-30A$21.98 M-43.35%
2016-06-30A$38.81 M4.36%
2015-06-30A$37.18 M91.61%
2014-06-30A$19.4 M72.69%
2013-06-30A$11.23 M-20.99%
2012-06-30A$14.22 M-36.95%
2011-06-30A$22.56 M8.08%
2010-06-30A$20.87 M143.97%
2009-06-30A$8.55 M-47.48%
2008-06-30A$16.29 M416.7%
2007-06-30A$3.15 M-79.58%
2006-06-30A$15.44 M20.34%
2005-06-30A$12.83 M-59.32%
2004-06-30A$31.54 M2557.16%
2003-06-30A$1.18 M
2001-06-30A$3.21 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$5.53 M-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.21 M-99.95% Bahamas